Clinical Trial Update: Methotrexate Followed by Fludarabine in Patients With T-Cell Large Granular Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluating methotrexate followed by fludarabine in patients with T-cell large granular lymphocytic leukemia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Large Granular Lymphocytic Leukemia

Drugs mentioned

• Fludarabine (Fludarabine)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: German CLL Study Group | Conditions: T-Cell Large Granular Lymphocytic Leukemia | Phase 2 | Status: TERMINATED